The healthcare sector is witnessing a important shift in glucose therapy with the introduction of GLP-1 transdermal devices. These revolutionary methods offer a likely convenient alternative to needle injections for individuals dealing with type 2 diabetes. By circumventing the need for frequent needles, GLP-1 patches promise to enhance user adhere